Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: healthadmin
People who are obsessed with anxiety become even more depressed when their partner doesn’t like them.
A daily diary study found that anxious and attached people tended to be more depressed and have lower self-esteem on days when they felt their partner liked them more. Relationship satisfaction was not affected. Rather, anxious and attached participants tended to feel more resentful and curious, and were more likely to retaliate. The paper was published in. personality journal. Phubbing is the act of ignoring or paying less attention to the person who is physically present because you are focused on your phone. This word is a combination of “telephone” and “sneer”. This can happen during conversations, meals, meetings, dates,…
Elaine’s story explores the boom in new obesity treatments, new drug payment models, the impact of FDA changes on companies, and the emerging psychedelic drug sector. She is a co-author of The Readout Newsletter and co-host of STAT’s weekly biotech podcast, The Readout Loud. Elaine can be reached at signal elaineywchen.70.CHICAGO — Rick Pazdur, the Food and Drug Administration’s former head of oncology regulation, said the damage done under recent political appointees opens an opportunity for new leadership to fundamentally reshape the agency, especially as China’s drug industry becomes more competitive. “We’ve experienced a lot of destruction here, but that…
For decades, the computing industry has followed a simple formula: make transistors smaller and put more of them on a chip. This strategy has facilitated the tremendous increase in computing power predicted by Moore’s Law. But as components approach the atomic scale, engineers are increasingly faced with silicon’s physical limitations and the effects of quantum mechanics. Many researchers believe that the next big breakthrough will not come from shrinking devices further, but from building them upwards. A team led by Qing Cao, a professor in the University of Illinois Granger College of Materials Science and Engineering, has demonstrated a new…
More than half of adults with ADHD in clinical settings also have a personality disorder.
Adults diagnosed with attention-deficit/hyperactivity disorder have a high rate of co-occurring personality disorders, but these numbers vary widely depending on how and where patients are evaluated. Recent analyzes suggest that more than half of adults seeking clinical help for this attention condition may also meet criteria for at least one personality disorder. The study, published in the journal Psychiatry Research, provides evidence that doctors should look beyond a single label to understand the complex mental health challenges facing this population. Attention-deficit/hyperactivity disorder, commonly known as ADHD, is a condition that usually begins in childhood and is characterized by an ongoing…
Adam Feuerstein is a senior writer and biotechnology columnist, reporting on the intersection of drug development, business, Wall Street, and biotechnology. He is co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. Signal’s Adam can be reached at stataf.54.CHICAGO — Biotechnology company Revolution Medicines has begun shipping an experimental life-prolonging treatment for pancreatic cancer to doctors and their patients under an early access program approved by the Food and Drug Administration, CEO Mark Goldsmith told STAT. “We’re shipping that drug right now,” he said Friday night, speaking at a STAT event held…
Scientists at Tokyo Metropolitan University have uncovered a key part of the biochemical pathway linking stress and sexual dysfunction. By studying the fruit fly Drosophila melanogaster, they showed that the neurotransmitter dopamine determines how long male flies exhibit sustained courtship inhibition after being confined to a small space, but not whether mating is inhibited in the first place. Their discoveries in key model organisms reveal the neurobiological factors that drive sexual dysfunction in other organisms, including humans. The biochemistry of stress is an important but poorly understood aspect of neurobiology. Exposure to internal or external stimuli is known to cause…
Pfizer appears to have once again surpassed Johnson & Johnson in the fight against PARP inhibitors in prostate cancer. Pfizer’s Talzenna and Xtandi combination, which won broader FDA labeling in metastatic castration-resistant prostate cancer (mCRPC), claims a Phase 3 win for a broader patient population with metastatic castration-sensitive prostate cancer (mCSPC) compared to J&J’s PARP doublet drug Akiga. At the 2026 American Society of Clinical Oncology Annual Meeting in Chicago, the Phase 3 Tarapro 3 trial showed that adding the PARP inhibitor Talzenna to Extandi significantly reduced the risk of radiographic progression or death by 52% in patients with homologous…
Explore the 2026 biopharma outlook focusing on M&A trends, AI in drug discovery, clinical pipelines, and regulatory strategies for pharmacologists and executives.
Implantation of collagen tiles doubles survival rates for patients with brain metastases
A multicenter clinical trial led by researchers at The University of Texas MD Anderson Cancer Center found that implanting collagen tiles and delivering targeted radiation therapy during brain surgery dramatically improves tumor control, lowers the risk of recurrence, and improves overall survival compared to the current standard of care for patients with newly diagnosed brain metastases requiring surgical resection. The ROADS trial, co-led by Jeffrey Weinberg, MD, professor of neurosurgery, and Thomas Beckham, MD, assistant professor of central nervous system radiation oncology, is the first randomized controlled Phase III trial comparing cesium-131 collagen tile-based radiation therapy (TBRT) with the standard…
About a decade ago, when ancient DNA research began to gain traction, geneticists took hold that everything modern humans thought they knew about European peoples was wrong. The story was simpler than anyone expected. Europe was settled in just three large-scale migrations from the East. Hunter-gatherers first appeared over 40,000 years ago. Then, 9,000 years ago during the Neolithic period, agricultural tribes expanded from Anatolia. Finally, starting 5,000 years ago, the Cordware people expanded from the Russian steppes, beginning the Bronze Age in Europe. Cordware, named for its cord-like impression on ceramics, has unique genetic characteristics that have not previously…